Topotecan Kabi 4 mg powder for concentrate for solution for infusion
Land: Bulgarien
Sprache: Bulgarisch
Quelle: Изпълнителна агенция по лекарствата
Gebrauchsinformation
(PIL)
17-07-2013
Fachinformation
(SPC)
17-07-2013
Wirkstoff:
Топотекан
Verfügbar ab:
Fresenius Kabi Oncology PLc
ATC-Code:
L01XX17
INN (Internationale Bezeichnung):
Topotecan
Dosierung:
4 mg powder for concentrate for solution for infusion
Produktbesonderheiten:
Topotecan Kabi, 4 mg powder for concentrate for solution for infusion x 1; x 5;
Berechtigungsdatum:
2013-11-06
